Ursodiol

Ursodiol
- In our pharmacy, you can purchase Ursodiol without a prescription, with worldwide delivery in 5–14 days. Discreet packaging.
- Ursodiol treats primary biliary cholangitis, cholesterol gallstones, and cholestasis by reducing bile cholesterol production and dissolving cholesterol-rich stones.
- The usual adult dosage is 8–15 mg/kg/day—typically ranging from 500 to 1000 mg daily—split into multiple doses based on body weight.
- Administered orally as tablets, capsules, or oral suspension.
- Therapeutic effects begin within days but may take weeks to months for full dissolution of gallstones.
- Requires daily dosing for chronic conditions like primary biliary cholangitis (often lifelong).
- Avoid alcohol consumption as it may exacerbate liver conditions.
- Most common side effects include diarrhea, nausea, abdominal pain, and loose stools.
- Would you like to try Ursodiol without a prescription?
Basic Ursodiol Information
Attribute | Details |
---|---|
INN (International Nonproprietary Name) | Ursodeoxycholic acid (Ursodiol) |
Brand names available in United Kingdom | Ursofalk, Actigall, Ursosan |
ATC Code | A05AA02 (bile acid therapy class) |
Forms & dosages | Tablets: 100mg, 250mg, 500mg | Capsules: 150mg, 250mg | Oral suspension: 250mg/5ml |
Manufacturers & suppliers | Zentiva, Dr. Falk Pharma UK, Terapia Ranbaxy |
UK registration status | MHRA-approved prescription medication |
OTC / Rx classification | Prescription-only (Rx) |
Medications containing ursodiol are used to treat specific bile and liver conditions. You'll find this treatment under different brand names across pharmacies in the United Kingdom. Proper storage requires keeping it below 25°C away from light and moisture. The prescription status means you must consult your GP or specialist before starting treatment.
Pharmacology And Mechanism
This bile acid treatment works primarily by altering bile composition. The mechanism involves dissolving cholesterol inside the gallbladder and liver bile ducts by reducing cholesterol saturation. When absorbed, it promotes bile flow, helping flush out cholesterol deposits that form gallstones. This activity makes it particularly effective for treating non-calcified cholesterol stones.
Concomitant Drug | Interaction Effect | Severity |
---|---|---|
Aluminum-based antacids | Reduces medication absorption by up to 40% | Moderate |
Cyclosporine | Decreases ursodiol effectiveness | Major |
Cholestyramine | Reduces bioavailability | Major |
The pharmacokinetic profile shows peak concentration occurs within 1-3 hours after oral administration. Gut bacteria metabolise most of the compound before it enters liver circulation. Regarding alcohol compatibility, moderate consumption hasn't shown significant synergistic hepatotoxicity risk, though heavy drinking remains ill-advised for liver patients. Always allow at least two hours between taking this medication and aluminum-containing antacids.
Approved Indications
Treatment applications vary between evidence-backed uses and carefully monitored off-label scenarios. Always follow your specialist's advice regarding appropriateness for your specific condition.
EU and FDA Approved Uses
- Primary biliary cholangitis management at 13-15mg/kg daily dosing
- Cholesterol gallstone dissolution for non-surgical candidates
Off-Label Applications in UK Practice
- Cystic fibrosis-related cholestasis under specialist hepatology guidance
- Non-alcoholic fatty liver disease adjunctive therapy in specific situations
Special population considerations show Category B pregnancy safety meaning potential benefits may outweigh risks in specific maternal health scenarios. Breastfeeding data suggests minimal transfer to breast milk. Pediatric cholestasis treatment requires hospital specialist oversight including weight-based dose calculations. Active liver cirrhosis with portal hypertension needs careful evaluation before starting treatment. Never attempt self-medication for gallstones without proper diagnostic imaging confirmation.
Availability and Pricing of Ursodiol in the UK Market
In the UK, Ursodiol – commonly prescribed under the brand name Ursofalk® – is accessible through major pharmacy chains like Boots and Lloyds Pharmacy via NHS or private prescriptions. While UK-manufactured generic versions exist, imported Ursofalk from Germany remains dominant for treating primary biliary cholangitis due to perceived reliability.
Cost Trends and Packaging Features
Monthly supply costs range between £45-£75 for 250mg capsules, depending on dosage strength and pharmacy. Prices have shown a 4-7% annual increase since 2020, attributed to imports and rising primary biliary cholangitis diagnoses (+5%/year nationally). Products approved by Romania's ANMDMR equivalent (MHRA/UK) typically utilise blister-packed capsules containing 50-100 units per box for medication stability.
Demand Drivers and Seasonal Patterns
Demand trajectories reflect UK gallstone prevalence (affecting 8-10% of adults) intersecting with higher winter hospitalisations for biliary colics. ANMDMR-registered pharmacies report surges in orders during autumn months alongside consistent primary biliary cholangitis management scripts – with Ursofalk UK cost regularly influencing prescription adherence decisions.
Future Research Directions and Evidence Quality
Between 2022-2025, research focuses on validating ursodiol's off-label applications beyond gallstone dissolution and primary biliary cholangitis management. Phase III trials actively investigate:
- High-dose regimens (≥20mg/kg/day) for non-alcoholic fatty liver disease reversal
- Histological improvements in NASH fibrosis
- Chemo-adjuvant roles in colorectal cancer protection
Market Changes and Meta-Analysis Findings
Recent patent expiries accelerated generic availability – notably Ursofalk in 2022 – diversifying supply chains. Studies like the Journal of Hepatology’s 2023 meta-analysis (68% gallstone dissolution rate) bolster clinical confidence despite generic competition. Current evaluations examine gallstone dissolution evidence suited to UK's rising obesity-linked biliary demands.
Frequently Asked Questions About Ursodiol Use
Patients regularly raise concerns that impact real-world adherence. These queries are grouped below:
Dosing Concerns and Management
Q: What protocol applies after missing Ursodiol?
A: Skip the missed dose if near the next scheduled dose; never double doses.
Q: Why avoid antacids around intake times?
A: Aluminium-based binders cut absorption by 40%.
Lifestyle Interactions
Q: Does Ursodiol alcohol interaction exist when drinking wine?
A: Minimal liver burden typically occurs, but enzyme monitoring is advised.
Guidelines for Optimal Administration and Safety
Proper Ursodiol administration requires strategic timing: ingest tablets alongside fatty meals to enhance dissolution. Avoid concurrent antacids, calcium supplements, or herbal liver remedies like milk thistle without pharmacist consultation due to unverified interactive risks.
Storage Recommendations and Critical Precautions
Maintain shelf stability by storing capsules below 25°C, discarding any showing discoloration immediately. Critical errors include self-treating suspected gallstones without CT confirmation – ineligible stones won't dissolve and may cause dangerous obstructions. Always review NHS-approved leaflets available during dispensing.